Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction

被引:0
作者
Hideki Yano
Shigeo Horinaka
Manami Watahik
Tomoko Watanabe
Toshihiko Ishimitsu
机构
[1] Dokkyo Medical University Hospital,Department of Cardiology and Nephrology
[2] Nasu Red Cross Hospital,Department of Cardiology
来源
Heart and Vessels | 2019年 / 34卷
关键词
Everolimus-eluting stent; Optical coherence tomography; ST-elevation myocardial infarction; Neointimal thickness; Apposition; Stent strut coverage;
D O I
暂无
中图分类号
学科分类号
摘要
Cobalt–chromium everolimus-eluting stent (CoCr EES) is associated with a lower rate of stent thrombosis even in patients with ST-elevation myocardial infarction (STEMI). However, the time-serial changes of endothelial coverage of the stent struts in the extremely early period have never been reported, especially in patients with STEMI. The aim of this study was to compare the vessel healing process between CoCr EES and cobalt–chromium bare metal stent (CoCr BMS) implantations using optical coherence tomography (OCT) in patients with STEMI. Sixty-three patients who had primary emergent percutaneous coronary intervention (PCI) with CoCr EES (42 patients) or CoCr BMS (21 patients) were enrolled in this study for 3 years. OCT was performed just after, 2 and 12 weeks after EES or BMS implantations. Time-serial changes in the neointimal coverage (NIC), the neointimal thickness, and malapposition of stent struts were evaluated. NIC of stent struts did not differ between CoCr EES (23.2%, 99.4%) and CoCr BMS (24.0%, 97.8%) at 2 weeks and 12 weeks after PCI, respectively. Thicknesses of the neointima on the stent strut was significantly thinner in CoCr EES (34.0 ± 13.8, 107.0 ± 32.4 µm) than in CoCr BMS (40.0 ± 14.6, 115.7 ± 33.8 µm) at 2 weeks and 12 weeks after PCI (p = 0.011, p = 0.008), respectively. The malapposition did not differ just after PCI, and was completely resolved at 12 weeks after PCI in both groups. Thrombus was significantly less in CoCr EES than in CoCr BMS at 2 weeks (19.0% vs 42.9%, p < 0.01), and decreased over time in both groups, but at 12 weeks, disappeared only in CoCr EES (CoCr EES: 0% vs. CoCr BMS: 4.8%, p = 0.56). This study demonstrated that NIC and apposition of the stent struts almost completed at 12 weeks after EES and BMS implantations, while the neointimal thickness on the stent struts were thinner in EES than in BMS. Moreover, thrombus was significantly less in EES than in BMS implantations 2 weeks after PCI, which may explain the lower rate of acute and subacute stent thrombosis of EES compared with BMS.
引用
收藏
页码:572 / 582
页数:10
相关论文
共 533 条
  • [41] Brophy JM(2009)Stent thrombosis in Sweden: a report from the Swedish coronary angiography and angioplasty registry Circ Cardiovasc Interv 2 401-408
  • [42] Eisenberg MJ(2009)Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J 30 321-329
  • [43] Jeremias A(2012)Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents Yonsei Med J 53 524-529
  • [44] Sylvia B(2011)Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 1400-1409
  • [45] Bridges J(2001)Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial Circulation 103 2816-2821
  • [46] Kirtane AJ(2016)2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Thorac Cardiovasc Surg 152 1243-1275
  • [47] Bigelow B(2016)Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography The HEAL-EES study. Cardiovasc Revasc Med 17 241-247
  • [48] Pinto DS(2012)Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimuseluting stent Trial (RESET) Circulation 126 1225-1236
  • [49] Ho KK(undefined)undefined undefined undefined undefined-undefined
  • [50] Cohen DJ(undefined)undefined undefined undefined undefined-undefined